Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-014328
Filing Date
2019-04-30
Accepted
2019-04-30 16:32:54
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q thor-10q_20190331.htm 10-Q 1620968
2 EX-31.1 thor-ex311_10.htm EX-31.1 7904
3 EX-31.2 thor-ex312_9.htm EX-31.2 7700
4 EX-32.1 thor-ex321_8.htm EX-32.1 8465
  Complete submission text file 0001564590-19-014328.txt   4692487

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT thor-20190331.xml EX-101.INS 822577
6 XBRL TAXONOMY EXTENSION SCHEMA thor-20190331.xsd EX-101.SCH 47168
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thor-20190331_cal.xml EX-101.CAL 40216
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thor-20190331_def.xml EX-101.DEF 109165
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE thor-20190331_lab.xml EX-101.LAB 292609
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thor-20190331_pre.xml EX-101.PRE 219576
Mailing Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037 (858) 750-4700
Synthorx, Inc. (Filer) CIK: 0001609727 (see all company filings)

EIN.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38756 | Film No.: 19782296
SIC: 2834 Pharmaceutical Preparations